At a glance
ClinicalIndex Comparison RecordN/ACompleted· 278 enrolled
Drug / intervention
Hearing amplificationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Unilateral vs Bilateral Hearing Aids for the Treatment of Age-related Hearing Loss
In Brief
A clinical study evaluating Hearing amplification for Hearing Loss. Completed, enrolled 278 participants across 2 sites.
Detailed Summary
This study aims to evaluate the benefit of bilateral hearing aid use compared to a unilateral hearing aid. Patients with mild to moderate bilateral hearing loss who are considering the purchase of a commercially available hearing aid will be considered for participation. Eligible participants will be randomized to one of the following treatment arms: (1) a bilateral hearing aid fitting group, and (2) a unilateral hearing aid fitting group.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
CollaboratorsPatient-Centered Outcomes Research Institute
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedFeb 2021
Enrollment StartApr 2021
Primary CompletionJul 2024
Study CompletionSep 2024
TodayJul 2026
First PostedFeb 4, 2021
Enrollment StartApr 26, 2021
Primary CompletionJul 12, 2024
Study CompletionSep 20, 2024
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 5.4 years ago
Interventions
Hearing amplificationdevice
Bilateral vs. unilateral hearing aids for hearing loss